Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Trial ID: NCT00185848
Age - 18 Years-N/A Condition - Brain (Central Nervous System, CNS) Cancers Gender - All Accepting Healthy Volunteers - No
The purpose of this study is to determine whether [18F]FHBG is suitable for use as an imaging
probe in cancer or rheumatoid arthritis patients enrolled in cell or gene therapy trials. In
this phase 1 study we will assess the safety and biodistribution of [18F]FHBG in patients.
Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.